Comprehensive Insights into the Molybdenum-99 Market: Growth, Emerging Trends, and Projections Through 2035
Overview:
The global molybdenum-99 market is poised for steady growth between 2025 and 2035. In 2025, the market is expected to reach a valuation of USD 5,166.4 million, driven by increasing demand for diagnostic and therapeutic applications in nuclear medicine. The market is projected to experience a compound annual growth rate (CAGR) of 4.6%, culminating in a revenue forecast of USD 7,744.1 million by 2035.
Molybdenum-99 (Mo-99) serves as the parent isotope for technetium-99m (Tc-99m), which is the most widely used radioisotope in medical imaging. The rising prevalence of cardiovascular diseases, cancer, and other chronic conditions requiring early and accurate diagnosis is a primary growth driver.
The North American region, particularly the United States, is anticipated to hold a significant share of the molybdenum-99 market, attributed to its advanced healthcare infrastructure and high adoption rate of nuclear medicine procedures. Europe, with countries like Germany and France, also represents a substantial market, fueled by ongoing research and development activities.
The Asia Pacific region is expected to witness the highest CAGR during the forecast period, driven by improving healthcare access, increasing healthcare expenditure, and a growing awareness of nuclear medicine techniques in countries like China and Japan.
However, the market faces challenges such as the limited number of Mo-99 production facilities, stringent regulatory requirements, and concerns regarding the disposal of radioactive waste. Efforts to develop alternative production methods and enhance supply chain resilience are crucial for sustained market growth.
Key players in the molybdenum-99 market include Curium Pharma, NorthStar Medical Radioisotopes, Institute for Radioelements (IRE), ANSTO, and NTP Radioisotopes. These companies are actively involved in expanding their production capacities and developing innovative solutions to address the growing demand for Mo-99.
Year On Year Growth Chart
“`html
| Report Attribute | Details |
|---|---|
| Market Size in 2025 | USD 5,166.4 million |
| Revenue Forecast for 2035 | USD 7,744.1 million |
| Growth Rate (CAGR) | 4.6% from 2025 to 2035 |
| Base Year for Estimation | 2024 |
| Historical Data | 2020 – 2024 |
| Forecast Period | 2025 – 2035 |
| Quantitative Units | Revenue in USD million/billion and CAGR from 2025 to 2035 |
| Report Coverage | Revenue forecast, company market share, competitive landscape, growth factors, and trends |
| Covered Segments | Application, end-user, and region |
| Regional Scope | North America, Europe, Asia Pacific |
| Country Scope | U.S., UK, European Union, Japan, South Korea |
| Key Companies Analyzed | Curium Pharma; NorthStar Medical Radioisotopes; Institute for Radioelements (IRE); ANSTO (Australian Nuclear Science and Technology Organisation); NTP Radioisotopes |
| Customization Options | Free report customization (up to 8 analysts working days) with purchase. Changes to country, regional, and segment scope |
| Pricing and Purchase Options | Customizable purchase options for tailored research needs |
“`
Key Companies Market Share
Report Coverage & Deliverables
- Market Trends And Dynamics
- Competitve Benchmarking
- Historical data and forecasts
- Value/Volume analysis
- Company revenue shares and key strategies
- Regional opportunities
This is an indicative segmentation. Please request a sample report to see detail segmentation of this market.
Detailed Market Segmentation
- By Application
- Medical Imaging
- Therapeutic Procedures
- Industrial Uses
- Research Applications
- By End-User
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical Companies
- Radiopharmaceutical Manufacturers
- By Region
- North America (U.S., Canada)
- Europe (Germany, France, UK, Italy, Spain)
- Asia Pacific (China, Japan, South Korea, Australia)
Table of Content
- Executive Summary
- Market Overview
- Key Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Molybdenum-99 Market Analysis, by Application
- Medical Imaging Market Analysis
- Therapeutic Procedures Market Analysis
- Industrial Uses Market Analysis
- Research Applications Market Analysis
- Molybdenum-99 Market Analysis, by End-User
- Hospitals and Clinics Market Analysis
- Research Institutes Market Analysis
- Pharmaceutical Companies Market Analysis
- Radiopharmaceutical Manufacturers Market Analysis
- Molybdenum-99 Market Analysis, by Region
- North America Market Analysis
- Europe Market Analysis
- Asia Pacific Market Analysis
- Competitive Landscape
- Company Profiles
- Research Methodology